In hemophilia A, several immune cells are involved in directing the immune response toward inhibitor development, and antigen presentations by APCs and subsequent activation of FVIII-specific CD4+ T cells appear to play a key role (7, 71, 72). The gene discussed is CD4; the disease is hemophilia A.